India, Sept. 3 -- FibroBiologics, Inc. (FBLG) announced that the U.S. Patent and Trademark Office has issued Patent No. 12,721,866 covering the therapeutic use of fibroblasts and fibroblast-derived materials for wound healing.
The newly granted patent protects methods of accelerating wound repair through topical administration of 3D spheroids and fibroblast-derived compositions, including extracellular vesicles, exosomes, and cell fragments.
chronic and nonhealing wounds such as diabetic foot ulcers, venous leg ulcers, bedsores, and burn injuries represent a major unmet medical need, often impairing quality of life and placing a heavy burden on healthcare systems.
Preclinical studies cited in the patent showed that wounds treated with fi...